Cardior
is a Germany-based biopharmaceutical company that researches and develops RNA-dependent therapies for the treatment of heart diseases... Read moreCardior
is a Germany-based biopharmaceutical company that researches and develops RNA-dependent therapies for the treatment of heart diseases... Read more
News
Apr 18, 2024
reuters
Cardior: German watchdog approves Novo's acquisition of Cardior Pharmaceuticals
Apr 18, 2024
Benzinga
Cardior: German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline
Mar 25, 2024
Beckers Hospital Review
Cardior: Novo Nordisk to buy heart drugmaker for $1.1B
Mar 25, 2024
BioPharma Dive
Cardior: Novo to acquire heart failure drug in deal for Cardior
Mar 25, 2024
Markets Insider
Cardior: Novo Nordisk to buy cardiac drug developer for up to $1.1B (NYSE:NVO)
Mar 25, 2024
MarketWatch
Cardior: Novo Nordisk targets heart disease in $1.1 billion deal
Mar 25, 2024
Pharamceutical Technology
Cardior: Novo shells out $1.1bn to buy Cardior to expand cardiovascular pipeline
Sep 08, 2022
Genomeweb
Cardior: Cardior Pharmaceuticals MicroRNA PCR Kit Receives CE Marking
Jul 21, 2022
PharmaTimes
Cardior: Cardior announces first patient dosed in phase 2 trial
Mar 02, 2022
FirstWord Pharma
Cardior: Cardior Appoints Experts to its Scientific Advisory Board
Cardior Competitors
1
2
3
4
5
6
7
8
9
10